Back to Search
Start Over
278 Preclinical development of LYL119, a ROR1-targeted CAR T-cell product incorporating four novel T-cell reprogramming technologies to overcome barriers to effective cell therapy for solid tumors
- Source :
- Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
- Publication Year :
- 2023
- Publisher :
- BMJ Publishing Group, 2023.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20511426
- Volume :
- 11
- Issue :
- Suppl 1
- Database :
- Directory of Open Access Journals
- Journal :
- Journal for ImmunoTherapy of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.8290649cd6d6401689d7af95ad7d49d4
- Document Type :
- article
- Full Text :
- https://doi.org/10.1136/jitc-2023-SITC2023.0278